Skip to main content
. 2022 Aug 19;5(8):e2227667. doi: 10.1001/jamanetworkopen.2022.27667

Table 1. Patient Characteristics.

Characteristic Patients, No. (%)
Case group with newly detected GC Matched control group without newly detected GC
Total patients, No. 107 107
Age, mean (SD), y 71.7 (7.2) 71.8 (7.0)
Sex
Male 94 (87.9) 94 (87.9)
Female 13 (12.1) 13 (12.1)
History of esophageal cancer
Absent 89 (83.2) 88 (82.2)
Present 18 (16.8) 19 (17.8)
History of gastric neoplasma
Absent 25 (23.4) 20 (18.7)
Present 82 (76.6) 87 (81.3)
Gastric mucosal atrophyb
Closed type 11 (10.3) 33 (30.8)
Open type 96 (89.7) 74 (69.2)
Helicobacter pylori infection
Positive 36 (33.6) 19 (17.8)
Positive and eradicated 67 (62.6) 48 (44.9)
Negative 3 (2.8) 9 (8.4)
Unknown 1 (0.9) 31 (29.0)
Aspirin use
Absent 100 (93.5) 90 (84.1)
Present 6 (5.6) 13 (12.1)
Unknown 1 (0.9) 4 (3.7)
Statin use
Absent 91 (85.0) 81 (75.7)
Present 15 (14.0) 19 (17.8)
Unknown 1 (0.9) 7 (6.5)
Smoking status
Present 11 (10.3) 10 (9.3)
Former 57 (53.3) 57 (53.3)
Never 27 (25.2) 25 (23.4)
Unknown 12 (11.2) 15 (14.0)
Alcohol consumption
Absent 35 (32.7) 36 (33.6)
Present 67 (62.6) 59 (55.1)
Unknown 5 (4.7) 12 (11.2)

Abbreviation: GC, gastric cancer.

a

Gastric neoplasms included GCs and gastric adenomas.

b

Presence of gastric mucosal atrophy was based on the classification system proposed by Kimura and Takemoto.15